Case File
efta-02575100DOJ Data Set 11OtherEFTA02575100
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02575100
Pages
6
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Friday, September 20, 2013 10:39 PM
To:
Alan S Halperin; Melanie Spinella
Subject:
Re: Sales Tax
no reason to retain them, that i can find, leon you =nd i need a discussion.
On Fri, Sep 20, 2013 at 6:34 PM, Alan S Halperin <=pan dir="Itr">
<mailto:
> wrote:
Ahhh.... Thanks. While Deloitte has=the experience and judgment, I don't think they had anything to add on=the
specific substantive issues (beyond what we knew). The insurance analo=y, while thoughtful, turned out not to work.
The suggestion that the grant=r continues to own the interest was rejected by others and, in my view, ra=ses the specter
of estate tax inclusion. Will you be retaining Deloitte? G=ven Amanda's commitment to give you the ruling, and given
the lack of =avorable authority, I think Ada's version is quite good.
IRS Circular 230 disclosure:
To ensu=e compliance with requirements imposed by the IRS, we inform you that any =.S. federal tax advice
contained in this communication (including any atta=hments) is not intended or written to be used, and cannot be used,
for the=purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) =romoting, marketing or recommending
to another party any transaction or ma=ter addressed herein.
Alan S. Halperin I Partner
Paul, Weiss, Rifkind, Wharton & Garri=on LLP
1285 Avenue of the Americas I New York, NY 10019-6064
(212= 373-3313 (Direct Phone) I (212) 492-0313 <tel:%28212%29%20492-0313> (Direct Fax)
mailto
> I www.=aulweiss.com
<http://www.paulweiss.com>
From: "Jef=rey Epstein" [[email protected] <mailto:[email protected]> I
Sent: 09/20/2013 06:08 PM AST
To: Alan Halperin
Subject: Re: Sales Tax
should we have deloitte put together their arguments , as =pposed to adas no consideration . theirs was more
regarding tranferi=g his right pocket to his left. my concern was that if the trust ass=ts were always in some sense his,
do we need to worry about 2036,
EFTA_R1_01746294
EFTA02575100
On Fri,=Sep 20, 2013 at 6:04 PM, Alan S Halperin IS»
wrote:
Jeffrey, I have be=ome quite good at interpreting your emails. But this last one has stumped me. I do
not have any idea what you mean by: "what about the argumen= , do we deloitte to try. what about2036 vs still his?"
Kindly spend tthree minutes and spell out your thoughts when you have a moment. Thanks. Alan
IRS Circular 230 disclosure:
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax
advice contained in this communication (including any attachments) is not intended or written to be used, and cannot
be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or
recommending to another party any transacti=n or matter addressed herein.=u>
Click Here for More Information
chttp://www.paulweiss.com/filesfibl_s29Publications/Fi=eUpload5679/5647/230.pdf>
Alan S. Halperin I Partn=r
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas I New York, NY 10019-6064
tel:%28212%29%20373-3313> (Direct Phone) I
<tel
(Direct Fax)</=ont>
/u> <mailt
I www.paulweiss.com</=>
<http://www.paulweiss.com/>
From:
=AO "Jeffrey Epstein" <jeevacation@=mail.com <mailto:[email protected]»
To:
Alan S Halperin/PaulWeiss@Pa=lWeiss
=A0 09/20/2013 05:57 PM
Subject:
Re: Sales Tax
what about the argument , do we deloitte to try.=AO what about2036 vs still his?
On Fri, Sep 20, 2013 at 5:45 PM, Alan S Halperin «=font
<mailto
> wrote:
I thought Ada's first draft was very good. It reflected my input. I told her to remove the reference to
defective grantor trust. Also, as noted on the call, the trust should be the taxpayer requesting the opinion. I assume that
you continue to believe that your other client should be the applicant. Correct?
2
EFTA_R1_01746295
EFTA02575101
Is my freeze partnership gaining any traction with you.
IRS Circular 230 disclosure:=/u>
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax
advice contained in this communication (including any attachments) is not intended or written to be used, and cannot
be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or
recommending to another party any transacti=n or matter addressed herein.
Click Here for More Information
<http://www.paulweiss.com/files/tbl_s29Publications/Fi=eUpload5679/5647/230.pdf>
Alan S. Halperin I Partner
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas I New York, NY 10019-6064
<tel
(Direct Phone)= I
<tel:
(Direct Fax)</=ont>
qu> <mailto
<http://www.paulweiss.com/>
I www.paulweiss.com</=>
From:
"Jeff=ey Epstein" <jeevacation=gmail.com <mailto:[email protected]»
To:
Alan S Halperin/PaulWeiss@PaulWeiss
09/20/2013 05:28 PM
Subject:
Re: Sales Tax
Please have them draft something you could live with . Leon will decide whether to file
On Friday, September 20, 2013, Alan S Halperin wrote:
Hi Jeffrey. I thought our call with Deloitte was quite productive. Pleas= note that, as described below,
the insurance analogy is not helpful. The reason is that there is a specific rule with insurance. The fact that there is an
express carve-out for insurance, but not in the substituti=n scenario, suggests that we should not use the former as
analogy to support the latter.
Tax Regs. Sec. 526.7(a)(5) provides the following, along with two examples:=/font>
The term "sale" does not apply to the transfer of tangible personal pro=erty to a carrier, repairman,
warehouseman or insurer by the owner of the proper=y after payment for damages thereto or loss thereof.
Example 1: A carrier while transporting tangible personal property for a customer, damages the
property. The carrier then make a cash payment to the customer for the amount the customer paid for the property,
and retains the damaged property. The retention of the property by the carrier is not a sale.
3
EFTA_R1_01746296
EFTA02575102
Example 2: A motor vehicle is damaged in an accident, and the insurer consi=ers it a total loss. The
insurer pays the owner cash, and takes the vehicle. The taking of the vehicle by the insurer is not a sale. The purchase of
another vehicle by the owner of the damaged vehicle, with the proceeds of the insurance, is a retail sale.
IRS Circular 230 disclosure:<=u>
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax
advice contained in this communication (including any attachments) is not intended or written to be used, and cannot
be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or
recommending to another party any transacti=n or matter addressed herein.
Click Here for More Information
<http://www.paulweiss.com/files/tbl_s29Publications/Fi=eUpload5679/5647/230.pdf>
Alan S. Halperin I Partn=r
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas I New York, NY 10019-6064
(Direct Phone)
<tel:
Direct Fax)</=ont>
<mailto
I www.paulweiss.com
This message is intended only for the use of th= Addressee and may contain information that is
privileged and confidential. If you are not the intended recipient, you are hereby notified that any dissem=nation of this
communication is strictly prohibited. If you have received this communication in error, please erase all copies of the
message and its attachments and notify us immediately.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected]=m <[email protected]=> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This message is intended only for the use of th= Addressee and may contain information that is
privileged and confidential. If you are not the intended recipient, you are hereby notified that any dissem=nation of this
communication is strictly prohibited. If you have received this communication in error, please erase all copies of the
message and its attachments and notify us immediately.
4
EFTA_R1_01746297
EFTA02575103
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected]=m cmailto:[email protected]=> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This message is intended only for the use of the Addressee =nd may contain information that is
privileged and confidential. If you ar= not the intended recipient, you are hereby notified that any disseminatio= of this
communication is strictly prohibited. If you have received this =ommunication in error, please erase all copies of the
message and its atta=hments and notify us immediately.
5
EFTA_R1_01746298
EFTA02575104
The informati=n contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside i=formation, and is intended only for
the use of the addressee. It is the=property of
Jeffrey Epstein
Unauthorized use, disclosure or copying=of this
communication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this
communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
This message is intended only for the use of the Addressee and =ay contain information that is privileged and
confidential. If you are no= the intended recipient, you are hereby notified that any dissemination of=this
communication is strictly prohibited. If you have received this comm=nication in error, please erase all copies of the
message and its attachme=ts and notify us immediately.
The information contai=ed in this communication is confidential, may be attorney-client privil=ged, may constitute
inside information, and is intended only for the use of the a=dressee. It is the property of Jeffrey Epstein Unauthorized
use, di=closure or copying of this communication or any part thereof is strictl= prohibited and may be unlawful. If you
have received this communication in error, p=ease notify us immediately by return e-mail or by e-mail to
[email protected], =nd destroy this communication and all copies thereof, including all attachm=nts. copyright -all
rights reserved
6
EFTA_R1_01746299
EFTA02575105
Technical Artifacts (17)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Phone
(212) 492-0313Phone
2575100Phone
2575101Phone
2575102Phone
2575103Phone
2575104Phone
2575105Phone
373-3313Phone
492-0313URL
http://www.paulweiss.comURL
http://www.paulweiss.com/files/tbl_s29Publications/Fi=eUpload5679/5647/230.pdfWire Ref
referenceWire Ref
reflectedRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.